EarlySight

EarlySight uses a novel approach to provide a single cell level imaging of the back of the eye, i.e. the retina. Its technology combines hardware and software to propose a unique medical device that can observe the cells affected at early-stage of the most prevalent retinal diseases such as age-related- macular degeneration (196 million people affected worldwide), glaucoma (76 million people affected worldwide) or diabetic retinopathy (95 million people affected worldwide), to treat them sooner and more efficiently.